Metformin Attenuates High Glucose‐Induced Coronary Vascular Endothelial Hyper Permeability Via Inhibition of Orai‐1 Mediated Store‐Operated Calcium Entry

Abstract

Increase in vascular endothelial permeability is an earliest pathological hallmark in diabetes mellitus, which progressively leads to cardiovascular disease. Stromal‐interaction molecule 1 (STIM1), upon sensing the depletion of calcium (Ca2+) from the endoplasmic reticulum (ER) store, organizes as a puncta that triggers store‐operated Ca2+ entry (SOCE) via plasmalemmal Ca2+‐selective Orai1 channels in endothelial cells. Thus, signals to disrupt endothelial cell‐cell junctions’ integrity and increase in endothelial permeability. Recent studies show that the anti‐diabetic drug metformin confers vascular benefits beyond glycaemia control and reduced the high risk of cardiovascular events in pre‐diabetes patients. However, the precise pharmacological role of metformin and the mechanism to regulate SOCE‐induced endothelial hyper permeability response in coronary vasculature remain enigmatic in the pathogenesis of hyperglycemia. Here, we demonstrate a previously undetermined role of metformin in inhibiting the Orai1 mediated induction of SOCE and thereby preventing the disintegration of vascular endothelial (VE) cadherin in high‐glucose exposed coronary vascular endothelial cells (ECs). Our data showed that exposing the human coronary endothelial cell monolayer to high glucose media (25mM) for 48 hours increased the expression of Orai1, protracted SOCE and the increased in endothelial permeability. We found that SOCE mediated by Orai1 activated the Pyk2 in ECs. Intriguingly, we observed the tyrosine phosphorylation of vascular endothelial‐protein tyrosine phosphatase (VE‐PTP) at tyrosine (Y) 1981 residue downstream of the Pyk2 activation in high glucose milieu. Our results showed that metformin prevented the SOCE by decreasing the expression of Orai1 and thereby abrogated the Pyk2 mediated phosphorylation of VE‐PTP in high glucose condition. Thus, led to the stabilization and maintenance of VE‐cadherin at interendothelial junctions and strengthening the barrier function. Our data identify heretofore unprecedented signaling mechanism by which metformin via inhibiting SOCE, maintains VE‐cadherin integrity and henceforth decreased high glucose induced hyper permeability response in human coronary endothelial cells.Support or Funding InformationThis work is supported by the Department of Pharmaceutical Sciences, Chicago State University College of Pharmacy (CSU‐COP) research funding to Mohammad Tauseef.